Stock DARE DARÉ BIOSCIENCE, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Consensus Daré Bioscience, Inc.

Equities

DARE

US23666P2002

Market Closed - Nasdaq
Other stock markets
 04:00:00 2024-07-10 pm EDT 		5-day change 1st Jan Change
3.32 USD +6.07% Intraday chart for Daré Bioscience, Inc. +7.44% -10.46%
Jun. 27 Dare Bioscience to Implement 1-for-12 Reverse Stock Split MT
Jun. 24 Dare Bioscience, Inc. Announces Publication in Obstetrics & Gynecology of Phase 2B Study Efficacy Results of Topical Sildenafil Cream, 3.6% for the Treatment of Female Sexual Arousal Disorder CI

Evolution of the average Target Price on Daré Bioscience, Inc.

Price target over the last 5 years

History of analyst recommendation changes

ee375efa576bb4ddec37bab557.mePpyGMJ49Rc7r1klrLUDMQ059wFsC82HUH8c9pg7Ok.66SZhTpEhIs4w98jo92NO7F7s7FCgRtZKRG-KYlTgrHJm4qgBmWygDSb5A~f5c33b32042cd1052536932f9d69f2cc

Analyst Recommendations on Daré Bioscience, Inc.

Brookline Capital Upgrades Dare Bioscience to Buy From Hold, Price Target is $3 MT
HC Wainwright Trims Price Target on Dare Bioscience to $6 From $7, Keeps Buy Rating MT
HC Wainwright Raises Price Target on Dare Bioscience to $7 From $6, Reiterates Buy Rating MT
JonesTrading Starts Dare Bioscience at Buy With $6 Price Target MT
Roth Capital Raises Price Target for Dare Bioscience to $17 From $11, Maintains Buy Rating MT
HC Wainwright Adjusts Dare Bioscience's Price Target to $6 from $5, Keeps Buy Rating MT
DARE BIOSCIENCE : Roth Capital Adjusts Price Target on Dare Bioscience to $11 From $9, Maintains Buy Rating MT
DARE BIOSCIENCE : HC Wainwright Initiates Coverage on Dare Bioscience With Buy Rating, $5 Price Target MT
More recommendations

Analysts' Consensus

Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
4
Last Close Price
3.32 USD
Average target price
52.25 USD
Spread / Average Target
+1,473.80%
High Price Target
72 USD
Spread / Highest target
+2,068.68%
Low Price Target
24 USD
Spread / Lowest Target
+622.89%

Consensus detail

Consensus revision (last 18 months)

Analysts covering Daré Bioscience, Inc.

Brookline Capital Markets
HC Wainwright
JonesTrading Institutional Services
Roth Capital Partners

Ratings for Daré Bioscience, Inc.

Trading Rating
Investor Rating
ESG Refinitiv
More Ratings

EPS Revisions

Estimates Revisions

Quarterly earnings - Rate of surprise

Company calendar
  1. Stock Market
  2. Equities
  3. DARE Stock
  4. Consensus Daré Bioscience, Inc.